News | September 26, 2022
NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
To set up 50 lifestyle modification centres across the UAE in the next 24 months
The plant at Raleigh, North Carolina, USA owned by Aurolife Pharma has received an establishment inspection report (EIR)
Diclofenac Sodium Topical Solution USP, 2% w/w (RLD Pennsaid) had estimated annual sales of US $484 million in the US
Charsire Biotechnology Corp. has successfully developed a revolutionary new drug (BAC) for Alzheimer's disease
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Subscribe To Our Newsletter & Stay Updated
